[1]
D. R. T. Subroto and I. P. B. Triguna, “A Severe Hyponatremia in a Renal Cell Carcinoma Patient Treated with Pembrolizumab: Possible Immune Checkpoint Inhibitor–Induced Secondary Adrenal Insufficiency”, InaJBCS, vol. 57, no. 3, pp. 46-47, Sep. 2025.